Topical exfoliation-clinical effects and formulating considerations

Cosmetic Formulation of Skin Care Products

Volumn , Issue , 2005, Pages 237-250

  Briden, M Elizabeth ^a   Green, Barbara A ^b  

^a Advanced Dermatology and Cosmetic Institute   (United States)

^b NeoStrata Company Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123745288     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Leveque JL, Saint-Leger D. Salicylic acid and derivatives. In: Leyden JJ, Rawlings AV, eds. Skin Moisturization. New York: Marcel-Dekker, 2002:353-364.
2. Del Rosso JQ. The many roles of topical salicylic acid. Skin & Aging 2005; 13:38-12.
3. Roberts DL, Marshall R, Marks R. Detection of the action of salicylic acid on the normal stratum corneum. Br J Dermatol 1980; 103:191-196.
4. Davies M, Marks R. Studies on the effect of salicylic acid on normal skin. Br J Dermatol 1976; 95:187-192.
5. Huber C, Christophers E. Keratolytic effect of salicylic acid. Arch Dermatol Res 1977; 257:293-297.
6. Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion and alpha hydroxy acids. J Am Acad Dermatol 1984; 11:867-879.
7. Kligman AM. A comparative evaluation of a novel low-strength salicylic acid cream and glycolic acid products on human skin. Suppl Cosmet Dermatol 1997;11-15.
8. Yu RJ, Van Scott EJ. a-hydroxyacids, polyhydroxy acids, aldobionic acids and their topical actions. In: Baran R, Maibach HI, eds. Textbook of Cosmetic Dermatology. 3rd ed. New York: Taylor & Francis, 2005:77-93.
9. Draelos ZD. The mechanisms of shaving: a complex interaction between the blade and the skin. Cosmet Derm 1993; 6:54-55.
10. Grove GL. Effect of daily cleansing with a polyester sponge on epidermal cell renewal. Poster presentation, New Orleans, La, February, 53rd Annual Meeting of the American Academy of Dermatology, 1995:4-9.
11. Bergfeld W, Tung R, Vidimos A, et al. Improving the cosmetic appearance of photoaged skin with glycolic acid. J Am Acad Dermatol 1997; 36:1011-1013.
12. Marti VPJ, Lee RS, Moore AE, et al. Effect of shaving on axillary stratum corneum. Int J Cosmet Sci 2003; 25:193-198.
13. Draelos ZD. Re-evaluating the mechanics of shaving. Cosmet Dermatol 1996; 9:11-14.
14. Hopping SB. The power peel: its emergence and future in cosmetic surgery. Int J Cosmet Surg 1988; 6:98-100.
15. Sadick NS, Finn N. A review of microdermabrasion. Cosmet Dermatol 2005; 18:351-354.
16. Kist D, Flor M, Zelickson B. Vibradermabrasion-new technique for superficial exfoliation. Cosmet Dermatol 2005; 18:131-135.
17. Lee WR, Shen SC, Kuo-Hsien W, et al. Lasers and microdermabrasion enhance and control topical delivery of vitamin C. J Invest Dermatol 2003; 121:1118-1125.
18. Bridges MA, Chrzanowski DS, Garrett AB, et al. The efficacy of facial microdermabrasion. Cosmet Dermatol 2003; 16:19-21.
19. Alam M, Omura NE, Dover JS, et al. Glycolic acid peels compared to mircrodermabrasion: a right-left controlled trial of efficacy and patient satisfaction. Dermatol Surg 2002; 28:475-479.
20. Coimbra M, Rohrich RJ, Chao J, et al. A prospective controlled assessment of microdermabrasion for damaged skin and fine rhytides. Plast Reconstr Surg 2004; 113:1438-1443.
21. Shim EK, Barnette D, Hughes K, et al. Microdermabrasion: a clinical and histopathologic study. Dermatol Surg 2001; 27:524-530.
22. Sparacio RM, Voigt A, Maes D, et al. A study comparing a novel home microdermabrasion system with a standard microdermabrasion procedure. Cosmet Dermatol 2004; 17:431-435.
23. J&J study shows home microdermabrasion efficacy on par with professional. The Rose Sheet, March 7, 2005:3.
24. Van Scott EJ, Yu RJ. Control of keratinization with alpha hydroxyacids and related compounds. Arch Dermatol 1974; 110:586-590.
25. Bond M, Van Scott EJ. New hydroxy acid formula for ichthyosis and other severe dry skin. Cosmet Dermatol 1998; 11:32-33.
26. Edison BL, Green BA, Wildnauer RH, et al. A polyhydroxy acid skin care regimen provides antiaging effects comparable to an alpha-hydroxyacid regimen. Cutis 2004; 73:14-17.
27. Yu RJ, Van Scott EJ. Alpha-hydroxyacids and carboxylic acid. Cosmet Dermatol 2004; 3:76-87.
28. 34th Report of the CIR Expert panel-safety of alpha hydroxy acid ingredients. Int J Toxicol 1998; 17.
29. Yu RJ, Van Scott EJ. Hydroxycarboxylic acids, N-acetylamino sugars, and N-acetylamino acids. Skin Med 2002; 2:117-122.
30. Berardesca E, Distante F, Vignoli GP, et al. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol 1997; 137:934-938.
31. Williams ML. Lipids in normal and pathological desquamation. In: Elias PM, ed. Advances in Lipid Research. New York: Academic Press, 1991:211-262.
32. Shapiro LJ, Weiss R, Webster D, et al. X-linked ichthyosis due to steroid sulphatase deficiency. Lancet 1978; 1:70-72.
33. Ditre CM, Griffin TD, Murphy GF, et al. Effects of alpha hydroxyacids on photoaged skin: a pilot clinical, histologic and ultrastructural study. J Am Acad Dermatol 1996; 34:187-195.
34. Bernstein EF, Underhill CB, Lakkakorpi J, et al. Citric Acid increases viable epidermal thickness & glycosaminoglycan content of sun-damaged skin. Dermatol Surg 1997; 23:689-694.
35. Bernstein EF, Uitto J. Connective tissue alterations in photoaged skin and the effects of alpha hydroxy acids. J Geriatr Dermatol 1995; 3:7A-18A.
36. Bernstein EF. Dermal effects of alpha hydroxyl acids. In: Moy R, Luftman D, Kakita L, eds. Glycolic acid peels. New York, NY: Marcel Dekker, 2002:71-113.
37. Griffin TD, Murphy GF, Sueki H, et al. Increased factor XlIIa transglutaminase expression in dermal dendrocytes after treatment with A-hydroxyacids. Potential physiologic significance. J Am Acad Dermatol 1996; 34:196-203.
38. Bernstein EF, Green BA, Edison B, et al. Poly hydroxy acids (PHAs): clinical uses for the next generation of hydroxy acids. Supplement to Skin & Aging. Skin Aging 2001; 9:4-11.
39. Bergfeld WF, Remzi BK, Green B. An evaluation of the gluconolactone sensitive skin care products. Poster presentation. February 1998: 56th Annual Meeting of the American Academy of Dermatology. FL: Orlando, 1998.
40. Rizer R, Turcott A, Edison B, et al. An evaluation of the tolerance profile of a complete line of gluconolactone-containing skin care fomulations in atopic individuals. Suppl Skin Aging 2001; 9:18-21.
41. Rizer R, Turcott A, Edison B, et al. An evaluation of the tolerance profile of gluconolactone-containing skin care fomulations in individuals with rosacea. Suppl Skin Aging 2001; 9:22-25.
42. Green BA, Edison BL, Wildnauer RH, et al. Lactobionic acid and gluconolactone: PHAs for photoaged skin. Cosmet Dermatol 2001; 9:24-28.
43. Grimes PE, Green BA, Wildnauer RH, et al. The use of polyhydroxy acids (PHAs) in photoaged skin. Cutis 2004; 73:3-13.
44. Briden ME, Green BA. The next generation hydroxyacids. In: Draelos Z, Dover J, Alam M, eds. Procedures in Cosmetic Dermatology: Cosmeceuticals. Philadelphia, PA: Elsevier Saunders, 2005:205-212.
45. Outwater S, Kohut BE, Greenspan AH, et al. An evaluation of the exfoliation efficacy of skin care formulations containing the poly hydroxy acid, gluconolactone. Suppl Skin Aging 2001; 9:26-30.
46. Van Scott EJ, Yu RJ. Bioavailability of alpha-hydroxy acids in topical formulations. Cosmet Dermatol 1996; 9:54-62.
47. Brackett W. The chemistry of salicylic acid. Therapeutic use of salicylic acid. Suppl Cosmet Dermatol 1997; 9:5-6.
48. Yu RJ, Van Scott EJ. Salicylic acid: not a beta-hydroxy acid. Cosmet Dermat 1997; 10:27.
49. Goldsmith LA. Salicylic acid. Int J Dermatol 1979; 18:32-36.
50. Lin AN, Nakatsui T. Salicylic acid revisited. Int J Dermatol 1998; 37:335-342.
51. Draelos ZD. Salicylic acid in the dermatologic armamentarium. Suppl Cosmet Dermatol 1997;7-8.
52. DiNardo JC. A comparison of salicylic acid, salicylic acid with glycolic acid and benzoyl peroxide in the treatment of acne. Cosmet Dermatol 1995; 8:43-44.
53. Elson ML. Salicylic acid peels in a new formulation for use in dermatologic surgery. J Clin Dermatol 1998; 1:36-39.
54. Lee HS, Kim IH. Salicylic acid peels for the treatment of acne vulgaris in asian patients. Dermatol Surg 2003; 29:1196-1199.
55. Kligman D, Kligman AM. Salicylic acid peels for the treatment of photoaging. Dermatol Surg 1998; 24:325-328.
56. Medansky RS, Duffie CA, Tanner DJ. Mometasone furoate 0.1% salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasis. Clin Ther 1997; 19:701-709.
57. Tost A, Piraccini BM, Cameli N, et al. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998; 139:655-659.
58. Brysk MM, Rajaraman S, Penn P, et al. Glycoproteins modulate adhesion in terminally differentiated keratinocytes. Cell Tissue Res 1988; 225:657-663.
59. Hudson DL, Sleeman J, Watt FM. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 1995; 108:1959-1970.
60. Data on file, NeoStrata Company, Inc., 2004.
61. Sayo T, Sakai S, Inoue S. Synergistic effect of N-acetylglucoseamine and retinoids on hyaluronan production in human keratinocytes. Skin Pharmacol Physiol 2004; 17:77-83.
62. Breborowicz A, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, et al. The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts. Adv Perit Dial 1998; 14:31-35.
63. Kikuchi K, Matahira Y. Oral N-acetylglucosamine supplementation improves skin conditions of female volunteers: Clinical evaluation by a microscopic three-dimensional skin surface analyzer. J Appl Cosmet 2002; 20:143-152.
64. Green BA, Edison BL, Wildnauer RH, et al. Derivatives of sugar compounds provide anti-aging effects. Poster presentation, Washington DC, February 2004: 62nd Annual Meeting of the American Academy of Dermatology.